Featured Products View All

 
 

Product News View All

sphingotec is Adding an Advanced POC Testing Platform to Portfolio
sphingotec is Adding an Advanced POC Testing Platform to Portfolio
Product News

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.

READ MORE

Biotech Support Group LLC Files Patent Application for Stroma Liquid Biopsy™
Biotech Support Group LLC Files Patent Application for Stroma Liquid Biopsy™
Product News

Methods to monitor and potentially modulate the systemic response to cancer, offer new avenues for early detection, personalized medicine and therapeutic modalities.

READ MORE

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease
Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease
Product News

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

READ MORE

Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab
Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab
Product News

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs.

READ MORE

 
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy